Noticias de Eulerpool Regenxbio

Regenxbio Noticias de Acciones

Regenxbio es observado por muchos periodistas e inversores en todo el mundo. Aquí recopilamos las noticias más recientes de Regenxbio.

• 18 de julio ·

  Yahoo
  REGENXBIO Inc. (NASDAQ:RGNX) is largely controlled by institutional shareholders who own 67% of the company
• 10 de julio ·

  Yahoo
  REGENXBIO Announces Publication of Preclinical Results Demonstrating Functional Benefits of Novel Microdystrophin Construct in RGX-202 Investigational Gene Therapy for Duchenne Muscular Dystrophy
• 20 de junio ·

  Yahoo
  Gene Therapy Was the Biggest Idea in Biotech. Now It Has Lost Support on Wall Street.
• 19 de junio ·

  Yahoo
  Gene Therapy Has Lost Support on Wall Street. There’s Still Hope for Big Cures.
• 13 de junio ·

  SeekingAlpha
  Undercovered Dozen: Kraken Robotics, Honeywell, Blue Owl Capital And More
• 5 de junio ·

  Yahoo
  REGENXBIO REPORTS NEW POSITIVE FUNCTIONAL DATA FROM PHASE I/II AFFINITY DUCHENNE® TRIAL OF RGX-202
• 2 de junio ·

  Yahoo
  REGENXBIO to Host Webcast Discussing Interim Functional Data from the Phase I/II AFFINITY DUCHENNE® Trial of RGX-202
• 19 de mayo ·

  Yahoo
  REGENXBIO Announces Strategic Royalty Monetization Agreement for Up to $250 Million
• 14 de mayo ·

  Yahoo
  Earnings Miss: REGENXBIO Inc. Missed EPS By 64% And Analysts Are Revising Their Forecasts
• 14 de mayo ·

  Yahoo
  FDA Accepts Biologics License Application for Mucopolysaccharidosis II Treatment